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Hepatitis C and health-related quality of life among
patients with hemophilia
Hemophilia is an X-linked bleedingdisorder caused by a partial orcomplete lack of clotting factor
activity. Health-related quality of life
(HRQoL) of these patients is lower than in
the general population and is mainly
dependent on severity of hemophilia, age,
orthopedic status and comorbidities.1-4
Hepatitis C is a major comorbid condition
among patients with hemophilia who
received non-virus-inactivated or insuffi-
ciently inactivated large-pool clotting fac-
tor concentrates or cryoprecipitate.5,6
Hepatitis C infection itself has also been
shown to be associated with a decrease in
HRQoL, which may be explained by
chronic liver disease and associated factors
present in many infected individuals, such
as intravenous drug use and low socio-
economic status.7-10 Reports about the
effect of hepatitis C virus (HCV) infection
on HRQoL in patients with hemophilia
are scarce. However, this information may
be important with regard to the policy on
initiating antiviral therapy. The majority
of reports on HRQoL among patients with
hepatitis C have focused on patients
selected for enrollment into treatment tri-
als, from which patients with hemophilia
are usually excluded.11,12
The aim of this study was to determine
the effect of HCV infection on HRQoL
among patients with hemophilia.
Methods
Data for the present study were collect-
ed within the last survey of a series initiat-
ed by Veltkamp in 1972.13 Since then
nationwide surveys were performed in
1978, 1985, 1992 and in 2001.14-16 These
surveys were aimed at assessing the med-
ical and social consequences of hemophil-
ia in the Netherlands. In 2001, postal ques-
tionnaires were sent to all 1519 known
hemophiliacs in the Netherlands, who
were either registered at the Netherlands
Hemophilia Patients’ Society or at the
hemophilia treatment centers, or known
from previous surveys. In this last survey
items on hepatitis C were added for the
first time. The study was approved by the
medical ethics committee of the Leiden
University Medical Center.
The overall response rate to the ques-
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Hepatitis C has a negative effect on health-related quality of life (HRQoL). It is not clear
whether hepatitis C affects HRQoL of patients with hemophilia. The objective of this
study was to assess the effect of hepatitis C virus (HCV) infection on HRQoL in
patients with hemophilia. A cross-sectional study was performed among all registered
hemophilia patients in the Netherlands. HRQoL was determined by using the self-
administered SF-36 questionnaire. Patients were eligible for the study if they complet-
ed the SF-36, had been treated with clotting factor products before 1992, and had
reported their hepatitis C status. Data on the severity of hemophilia were obtained
from the hemophilia treatment centers. The validity of the self-reported data on hepa-
titis C status was verified in a random sample of 92 (15%) patients; 92% reported their
hepatitis C status correctly. Fifty-five percent (333/602) of the study population had a
current HCV infection. All eight domains of the SF-36 were lower in patients with a cur-
rent HCV infection than they were in patients who had never been infected with HCV.
After adjustment for age, severity of hemophilia, human immunodeficiency virus (HIV)
status, employment status, and joint limitations, hepatitis C infection was associated
with a decrease of HRQoL on the domains of general health (difference 6.9 [95% con-
fidence interval (C.I.) 2.7 to 11.2]) and vitality (3.8 [95% C.I. 0.1 to 7.7]). Hemophilia
patients infected with HCV scored lower on the HRQoL domains of general health and
vitality than hemophilia patients who had never been infected with HCV.
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tionnaire was 70% (1066/1519). Of those responding
to the questionnaire, 771 patients had been treated
with clotting factor products before 1992 and were at
risk of HCV infection. Of those at risk, 638 patients
reported their HCV test result and 602 completed the
SF-36 questionnaire. The study population consisted
of these 602 patients, treated with clotting products
before 1992, with a reported HCV test result and a
completed SF-36 questionnaire. Hemophilia type and
severity of patients not responding to this question-
naire (n=453) were similar to those of the responding
population (n=1066). The reasons for these patient’s
lack of participation in this study are not known.
Socio-demographic and clinical data of patients at
risk for HCV, who did not complete the SF-36 ques-
tionnaire (n=36) did not differ from those of the
study population (n=602).
The questionnaire contained questions on type and
severity of hemophilia, use of clotting products,
health issues, complications and infections, educa-
tion, and profession. The self-reported type and
severity of hemophilia were verified with informa-
tion from the treatment centers. 
Hepatitis C status was defined as: never infected
with HCV, infection in the past, or current infection.
To assess the validity of the self-reported data on
hepatitis C, a random sample of 92 patients (15%)
was drawn from the two largest participating centers
and these data were verified with information from
the treating hematologists. 
HRQoL was assessed by using the Dutch version
of the SF-36 questionnaire.17-19 This self-administered
questionnaire contains 36 items assessing 8 domains
of HRQoL: physical functioning, social functioning,
role physical, role emotional, mental health, vitality,
bodily pain and general health. Each HRQoL domain
is given a score ranging from 0 to 100, with higher
scores indicative of better quality of life. In addition,
the physical and mental health component sum-
maries were calculated using standard algorithms.20
Table 1 explains the meaning of the different
domains.
Joint status was assessed in terms of functional lim-
itation of 16 joints; per joint, scores ranged from 0 (no
limitation), 1 (some limitation without daily prob-
lems), 2 (some limitation with daily problems), to a
maximum of 3 (severe limitation with complete loss
of function). The total joint limitation score was calcu-
lated by adding up all joint scores resulting in a range
from 0 to 48. 
Employment and educational status were deter-
mined by asking patients about their work or school.
Descriptive statistics were calculated using means
(95% confidence intervals, C.I.) and medians (range).
Baseline characteristics and HRQoL scores of
patients with a current HCV infection were com-
pared with those of patients who had never been
infected using the T-test for continuous and normal-
ly distributed data, the Mann-Whitney U-test for
continuous and skewed data and the χ2-test for ordi-
nal or nominal data. A p value <0.05 was considered
statistically significant.
To quantify the effects of HCV infection on
HRQoL, linear regression models were used with
physical and mental summary scores as dependent
variables. In order to facilitate the interpretation of
the effect of hepatitis C on HRQoL and to put this
effect in perspective, we also determined the isolated
effects of both age and severity of hemophilia on
HRQoL. The effect of age was assessed in patients
with mild hemophilia who had never been infected
with HCV. The effect of disease severity was deter-
mined by comparing patients with mild versus
severe hemophilia, among patients who had never
been infected with HCV.
Multivariate linear regression models were used to
adjust the association between HCV infection and
HRQoL for age, severity of hemophilia, HIV status,
joint limitation and employment/education status.
Dummy variables for hepatitis C infection status and
severity of hemophilia were created to differentiate
among the groups in the regression analyses; the ref-
erences were never infected with HCV and mild hemo-
philia’, respectively. The regression coefficients repre-
sent the change in outcome (i.e. scores on domains of
HRQoL), per unit increase of the determinant. 
Results
The study population consisted of 602 patients; 171
(28%) patients had never been infected with HCV, 98
(16%) had cleared HCV, and 333 (55%) patients had a
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Table 1. Explanation of the domains of the SF-36.
Domain Explanation
Physical functioning Limitations in daily activities (e.g. walking, dressing)
Social functioning Limitations in social activities (e.g. meeting friends) 
Role physical Difficulties with work or daily activities due to physical 
health problems
Role emotional Difficulties with work or daily activities due to emotional 
problems
Mental health Presence of depressive feelings or nervousness
Vitality Loss of energy or presence of fatigue
Bodily pain Presence of pain and its limitations due to pain
General health Subjective evaluation of general health status
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current HCV infection. In the verification sample, 92%
(85/92) reported their hepatitis C status correctly; these
proportions were 93%, 75% and 100% for patients
with a current infection, an infection in the past, and
patients who have never been infected, respectively.
Table 2 presents the patients’ characteristics according
to hepatitis C status. Patients with a current HCV infec-
tion were older than those who had never been infect-
ed (44 years vs. 37 years). Furthermore, the proportions
of patients with severe hemophilia and HIV, and total
score of joint limitations were higher among patients
currently infected with HCV than among patients who
had never been infected. Patients with a current HCV
infection had lower HRQoL scores on all domains and
the physical component summary of the SF-36 ques-
tionnaire compared to those who had never been
infected (Figure 1). Physical function, role physical and
general health appeared to be the domains most affect-
ed by HCV infection. The mental component summa-
ry was similar in all groups.
In order to study potential confounders of the associ-
ation between hepatitis C and HRQoL, we performed
univariate analysis of several established determinants
of HRQoL on the physical and mental component sum-
maries of the SF-36 questionnaire (Table 3). Current
HCV infection, increasing age, severe hemophilia, HIV,
increasing joint limitation and unemployment were
associated with lower scores on the physical compo-
nent summary score. A lower score on the mental com-
ponent summary was associated with increasing age,
increasing joint limitation and unemployment.
However, the effects of these determinants on the men-
tal component summary were less pronounced than
the effects on the physical component summary score.
A current HCV infection was associated with lower
scores on all domains but the mental component sum-
mary score in the univariate analysis. After adjustment
for age, severity of hemophilia, HIV status, joint limita-
tions and employment/educational status, current HCV
infection was only associated with a statistically signif-
icant decrease of the scores for general health (-6.9,
95% C.I. -11.2 to -2.7) and vitality (-3.8, 95% C.I. -7.7
to -0.1). In order to facilitate the interpretation of the
effect of hepatitis C on the HRQoL domains of gener-
al health and vitality by putting this effect into per-
spective, we studied the isolated effects of age and
severity of hemophilia on these domains (Table 5). For
every 10 years the score of vitality decreased by 1.2
points (95% C.I. -1.1 to 3.5) and the score of general
health by 1.7 points (95% C.I. -0.7 to 4.2) among
patients with mild hemophilia without hepatitis C. We
found no effect of disease severity on general health
and vitality: scores were similar in patients with severe
and mild hemophilia without hepatitis C. 
Discussion
In this nationwide study among 602 patients with
hemophilia, patients with a current HCV infection
scored lower than patients who had never been infect-
ed on all eight domains and the physical component
summary of the SF-36 questionnaire. However, after
adjustment for joint limitations, HIV status, age,
employment/educational status, and severity of hemo-
philia, only the scores on the domains of general health
and vitality of patients with HCV infection were affect-
ed.
To appreciate our findings some limitations of this
study need to be discussed. Self-reported data may be
Table 2. Baseline characteristics of the study population according
to HCV infection status.
Never Infection Current P
infected in the past infection value*
(n=171) (n=98) (n=333)
Age (years) 37 36 44 <0.001
(11-87) (13-87) (13-83)
Severe hemophilia 24% 55% 60% <0.001
HIV positive 1% 2% 7% <0.005
Joint limitation score 2 4 7 <0.001
(0-48) (0-48) (0-32) (0-35)
Employed/student 81% 80% 70% <0.01
Values are medians (range) or percentages. *Differences in baseline
characteristics; patients who had never been infected compared with patients
with a current HCV infection. 
Table 3. Crude effects of patients’ characteristics on physical and





Current HCV -8.4 (-10.5 to -6.3)§ -0.9 (-2.7 to 1.0)
Age (per 10 years) -2.7 (-3.3 to -2.2)§ -0.8 (-1.3 to -0.3)‡
Severe hemophilia -8.0 (-10.0 to -5.9)§ 1.2 (-0.6 to 3.1)
Joint limitation (per point) -1.1 (-1.2 to -1.0)§ -0.2 (-0.3 to -0.1)§
HIV positive -6.4 (-11.1 to -1.7)‡ 2.4 (-1.5 to 6.3)
Employed/student* 11.3 (9.3 to 13.3)§ 4.7 (2.8 to 6.5)§
Values are regression coefficients (95% confidence interval).*patients were
classified as ‘employed’ when they worked full- or part-time; the young patients
were classified as students as they attended school. ‡p value < 0.05. §p-value <
0.001; The presence of a current HCV infection resulted in a decrease of 8.4 points
of the physical component summary. 
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unreliable. We therefore performed a validation study
to check the accuracy of reported hepatitis C status,
and found that these self-reported data were reliable.
This confirms previous observations that most patients
with hemophilia are well informed about their disease
and its complications.15
Several studies have shown impaired HRQoL among
patients with HCV infection compared with healthy,
non-institutionalized members of the general popula-
tion.7-10,21,22 The effect of having HCV infection in the
non-hemophilia population has been shown to lower
the HRQoL score in the range from 10 to 30 points with
the domains of role physical, general health, vitality
and role emotional being most frequently affected.
Hemophilia itself is also associated with a lower
HRQoL compared with that found in the general pop-
ulation.1,4 Increasing age, severe hemophilia, orthopedic
status and HIV are reported to be predictors of a
decreased HRQoL in patients with hemophilia.1-4 The
effect of hepatitis C on HRQoL in patients with hemo-
philia is unclear. One study reported a decreased
HRQoL in hemophilia patients caused by hepatitis.2
However, HRQoL was determined by the health utili-
ty index and hepatitis B and C were taken as one deter-
minant in the analyses. This might be inappropriate as
Foster et al. showed that hepatitis B and C have differ-
ent effects on HRQoL.8 After adjustment for confound-
ing factors, we found that current HCV infection was
associated with lower scores on the domains of gener-
al health and vitality only. These effects were relatively
small but significantly stronger than the isolated effects
of age and hemophilia severity. This indicates an
important effect of hepatitis C on specific domains of
HRQoL (vitality and general health) in patients with
hemophilia. 
Figure 1. Crude HRQoL according to HCV infection
status. Patients who had never been infected had
higher scores (p<0.05) on all domains and the phys-
ical component summary score (PCS) compared
with patients with a current HCV infection; the men-
tal component summary score (MCS) was similar in
all groups. PF: physical functioning; SF: social func-
tioning; RP: role physical; RE: role emotional; MH:
mental health; VT: vitality; BP: bodily pain; GH: gen-
eral health.
Table 4. Crude and adjusted effects of current HCV infection on all
domains of the SF-36.
HRQoL domain β current β current
HCV (95% CI) HCV (95% CI)
unadjusted adjusted*
Physical functioning -22.1 (-27.5 to -16.8)‡ -1.6 (-5.4 to 2.1)
Social functioning -9.6 (-14.1 to -5.1)‡ -3.2 (-7.7 to 1.2)
Role-physical -19.5 (-27.0 to -12.0)‡ -4.9 (-12.3 to 2.6)
Role-emotional -11.1 (-17.6 to -4.7)† -3.5 (-10.3 to 3.3)
Mental health -4.0 (-7.2 to -0.8)† -2.7 (-6.1 to 0.8)
Vitality -6.5 (-10.1 to -2.8)† -3.8 (-7.7 to -0.1)†
Bodily pain -12.7 (-17.2 to -8.3)‡ -3.5 (-7.8 to 0.9)
General health -13.5 (-17.6 to -9.4)‡ -6.9 (-11.2 to -2.7)†
Physical component score -8.4 (-10.5 to -6.3)‡ -1.6 (-3.4 to 0.1)
Mental component score -0.9 (-2.7 to 1.0) -1.5 (-3.6 to 0.6)
Values are regression coefficients (95% confidence interval); *adjusted for age,
severity of hemophilia, joint limitation, HIV and employment status;
†p-value < 0.05; ‡p-value < 0.001. Interpretation: the crude score on general health
in patients with HCV infection was 13.5 points lower than that in patients who
had never been infected with HCV. After adjustment the score for general health
was 6.9 points lower in patients infected with HCV than in patients never infected
with HCV. 
Table 5. Effects of age and severe hemophilia on the domains of
vitality and general health of the SF-36 (univariate regression).
Vitality General health
Age (per 10 years) -1.2 (-3.5 to 1.1) -1.7 (-4.2 to 0.7)
Severe hemophilia -0.1 (-7.1 to 6.9) 0.6 (-6.6 to 7.8)
Values are regression coefficients (95% confidence interval). Regression
coefficients for age were determined in patients with mild hemophilia and who
had never been infected with HCV. Regression coefficients for severe hemophilia
were determined in patients who had never been infected with HCV, with mild
hemophilia as the reference variable. 
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Hepatitis C may reduce HRQoL through several
mechanisms. Commonly reported symptoms of
fatigue and tiredness may be partly responsible for this
decrease. This is supported by two studies among HCV
infected intravenous drug users showing lower scores
of general health and vitality in patients aware of their
hepatitis C status.23,24 It was suggested that a diagnosis
of hepatitis C raised concern and fear about current and
future health status, resulting in a lower HRQoL. Fear
about present and future health status is expected to
predominantly affect the domain of general health.
Indeed, in our study in which almost all patients were
aware of their hepatitis C status, the domain of gener-
al health was affected most by the presence of HCV
infection. 
The majority of patients with hepatitis C in this
study population have not been treated.25 However, our
findings demonstrate that specific domains of HRQoL
are impaired among patients with hemophilia and hep-
atitis C. These results support the initiation of antiviral
treatment in this population, as successful treatment for
hepatitis C has been proven to improve HRQoL and to
be cost-effective as well.11
In conclusion, hemophilia patients infected with
HCV had a lower HRQoL than hemophilia patients
who were not infected with HCV. Current HCV infec-
tion was associated with lower scores on the domains
of general health and vitality. 
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